Back
HFA Premium Access

Efficacy of Tolvaptan for the first hospitalized patients with acute decompensated heart failure

Session: Poster Session 2 - Acute Heart Failure– Treatment
Topic: Pharmacotherapy
Speaker: Doctor Y. Suzuki (Nagakute-cho, JP)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Yoriyasu Suzuki

Aichi Medical University, Nagakute-cho (Japan)
0 follower

11 more presentations in this session

Digoxin and Prognosis of Heart Failure in Older Patients with Preserved Ejection Fraction: Importance of Heart Rate

Speaker: Doctor P. Llacer (Madrid, ES)

Access
Abstract
Like
Thumbnail

Elegibility for sacubitril/valsartan utilization in acute heart failure

Speaker: Associate Professor L. Passos (Salvador, BR)

Access
Abstract
Slides
Like
Thumbnail

Safety and efficacy of tolvaptan administration in patients hospitalised for acute decompensated heart failure due to moderate or severe aortic stenosis

Speaker: Doctor R. Hata (Kurashiki, JP)

Access
Abstract
Slides
Like
Thumbnail

Effects of low dose levosimendan on renal function in patients with advanced heart failure

Speaker: Doctor R. Dierckx (Aalst, BE)

Access
Abstract
Like
Thumbnail

Using Levosimanden in place for unresponsive acute decompensated heart failure to dobutamine

Speaker: Doctor M. Chou (Tainan, TW)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Acute Heart Failure– Treatment

Speakers: Doctor Y. Suzuki, Doctor P. Llacer, Associate Professor L. Passos, Doctor R. Hata, Doctor R. Dierckx...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources